On 2015 Jun 08, Prof.Dr.Jogenananda Pramanik commented:

Invited co-authors: Dr.Cao Yulin MD.PhD CEO, International Centre for Biogenetics and Stem Cell Research ( ICBSCR), Beijing; Dr.Juntang Lin, Research Group Leader, Jena University, Jena, Germany.

Despite rigorous internal and external quality control measures and close supervision from China Academy of Sciences and related Governmental regulatory agencies, we humbly accept that certain limitations and risk factors that are existing in stem cell therapeutic procedures in China like any other developed countries. However, we are painfully conscious to observe the organized efforts to hinder the flow of patients from western world to different hospitals in China seeking stem cell therapy for different disorders. Since past few years stem cell therapy is picking up tremendous popularity among patients recovering from incurable diseases like cerebral palsy, IDDM and others. Amidst several restrictions, stem cell therapy is practised in India, Malaysia and other South East Asian countries. Governmental regulatory bodies are sincerely employing necessary regulations where ever required and therefore their efforts are commendable in view of the safety of our patients. As all of us understand that virtually no medical treatment is without risk and so is for cell-based therapy in general. However, as stem cell research progresses and legitimate medical innovation using stem call-based applications become more of a reality, all those issues will hopefully be settled step by step. We in no way wish to place any blame on individuals who are determined to pursue hope in what are often extremely difficult and discouraging circumstances (1 & 2). References: 1.Editorial:Stem-cell laws in China fall short: Nature;467,633(07 October 2010/ doi.10.1038/467633a. 2.Jogenananda Pramanik & Tanu Pramanik: Stem Cell Therapy Controversial? Re: Netherlands bans stem cell therapy:BMJ2007;334doi.http;//dx.doi.org/10.1136/bmj.39072458449.DB(Published 04 January 2007)

On 2015 Jun 08, Prof.Dr.Jogenananda Pramanik commented:

Invited co-authors: Dr.Cao Yulin MD.PhD CEO, International Centre for Biogenetics and Stem Cell Research ( ICBSCR), Beijing; Dr.Juntang Lin, Research Group Leader, Jena University, Jena, Germany.

Despite rigorous internal and external quality control measures and close supervision from China Academy of Sciences and related Governmental regulatory agencies, we humbly accept that certain limitations and risk factors that are existing in stem cell therapeutic procedures in China like any other developed countries. However, we are painfully conscious to observe the organized efforts to hinder the flow of patients from western world to different hospitals in China seeking stem cell therapy for different disorders. Since past few years stem cell therapy is picking up tremendous popularity among patients recovering from incurable diseases like cerebral palsy, IDDM and others. Amidst several restrictions, stem cell therapy is practised in India, Malaysia and other South East Asian countries. Governmental regulatory bodies are sincerely employing necessary regulations where ever required and therefore their efforts are commendable in view of the safety of our patients. As all of us understand that virtually no medical treatment is without risk and so is for cell-based therapy in general. However, as stem cell research progresses and legitimate medical innovation using stem call-based applications become more of a reality, all those issues will hopefully be settled step by step. We in no way wish to place any blame on individuals who are determined to pursue hope in what are often extremely difficult and discouraging circumstances (1 & 2). References: 1.Editorial:Stem-cell laws in China fall short: Nature;467,633(07 October 2010/ doi.10.1038/467633a. 2.Jogenananda Pramanik & Tanu Pramanik: Stem Cell Therapy Controversial? Re: Netherlands bans stem cell therapy:BMJ2007;334doi.http;//dx.doi.org/10.1136/bmj.39072458449.DB(Published 04 January 2007)